Trial Profile
Phase II study of asparaginase (ERY-ASP) in Diffuse Large B-Cell Lymphoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs ERY-ASP (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 01 Apr 2015 New trial record
- 30 Mar 2015 According to ERYtech media release, this trial is expected to begin during 2015.